ATC 2024 Concludes with Outstanding Attendance and Promising Impact
July 08 2024 - 9:00AM
Business Wire
The Joint Annual Congress Highlights
Encouraging Progress and Achievements in Organ Transplantation
The American Transplant Congress (ATC 2024) announced the
conclusion of its joint annual event, marking the culmination of a
momentous gathering dedicated to advancing the field of organ
transplantation. Held from June 1-5th in Philadelphia, PA – the
event, produced by the American Society of Transplantation (AST)
and the American Society of Transplant Surgeons (ASTS), brought
together leading transplant professionals, researchers and
advocates from around the world to exchange knowledge, foster
collaboration and drive innovation in the pursuit of improved
patient outcomes.
ATC 2024 attendees were immersed in a diverse program of 214
scientific sessions, including Hot Topic Debates, Rapid Fire Oral
Abstract Presentations and Symposia. These covered a wide
spectrum of topics ranging from organ procurement, allocation,
immunosuppression, xenotransplantation, robotic surgery and more.
Additionally, experts also presented more than 1250 poster
abstracts in the Exhibit Hall. Esteemed leaders in the
space, Peter Friend, MD, and the Honorable Alex M. Azar II,
delivered the 2024 State-of-the-Art Lectures, sharing
cutting-edge insights on organ perfusion and a fireside chat on the
most pressing challenges facing the transplant community,
respectively.
“ATC 2024 serves as a cornerstone event for the transplantation
community, providing a unique platform for interdisciplinary
collaboration and learning,” said Jon Kobashigawa, MD, President of
AST. “We are thrilled to have witnessed such robust engagement and
knowledge exchange among our attendees, reflecting our collective
commitment to advancing the science and practice of organ
transplantation.”
Key highlights from ATC 2024 include:
- 2,270 complete abstract submissions, underscoring
the increasing interest in transplantation research.
- A special session celebrating the 70th anniversary of the first
successful living donor transplant, special late breaking
abstracts, and a strong focus on clinical trials.
- 4,652 transplant professionals and stakeholders in
attendance, representing 49 countries, fostering a truly
global exchange of ideas and expertise.
- 120 industry partners and exhibitors showcasing the
latest innovations in transplant medicine, from novel
immunosuppressive therapies to state-of-the-art organ preservation
technologies.
“As we reflect on the success of ATC 2024, we are energized by
the collective commitment and dedication of the transplant
community to advancing the field,” added Ginny L. Bumgardner, MD,
PhD, President of ASTS. “The insights gained, and connections
forged during this congress will undoubtedly propel us forward in
our mission to improve precision medicine and overcome current
challenges in transplantation.”
For more information about ATC 2024 or to become a member of AST
and/or ASTS, visit: atcmeeting.org.
The American Society of Transplantation (AST), founded in 1982
is an organization of more than 3,500 professionals dedicated to
advancing the field of transplantation and improving patient care
by promoting research, education, advocacy, and organ donation. The
society is the largest transplant organization in North America and
is recognized as the premier society for transplantation. AST
members are sought out as transplant experts and advocates.
The American Society of Transplant Surgeons (ASTS) was founded
in 1974 by 127 surgeons to unite the professionals who were
advancing the fledgling field of organ transplantation. From this
small group of dedicated individuals, the society has grown to
represent over 2,000 transplant professionals who are dedicated to
saving and improving lives through the transformative power of
organ donation and transplant surgery.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240708714144/en/
Catherine Lockwood | media@atcmeeting.org